Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
A TLR/AKT/FoxO3 immune tolerance–like pathway disrupts the repair capacity of oligodendrocyte progenitors
Taasin Srivastava, … , Larry S. Sherman, Stephen A. Back
Taasin Srivastava, … , Larry S. Sherman, Stephen A. Back
Published April 16, 2018
Citation Information: J Clin Invest. 2018;128(5):2025-2041. https://doi.org/10.1172/JCI94158.
View: Text | PDF
Research Article Inflammation Neuroscience

A TLR/AKT/FoxO3 immune tolerance–like pathway disrupts the repair capacity of oligodendrocyte progenitors

  • Text
  • PDF
Abstract

Cerebral white matter injury (WMI) persistently disrupts myelin regeneration by oligodendrocyte progenitor cells (OPCs). We identified a specific bioactive hyaluronan fragment (bHAf) that downregulates myelin gene expression and chronically blocks OPC maturation and myelination via a tolerance-like mechanism that dysregulates pro-myelination signaling via AKT. Desensitization of AKT occurs via TLR4 but not TLR2 or CD44. OPC differentiation was selectively blocked by bHAf in a maturation-dependent fashion at the late OPC (preOL) stage by a noncanonical TLR4/TRIF pathway that induced persistent activation of the FoxO3 transcription factor downstream of AKT. Activated FoxO3 selectively localized to oligodendrocyte lineage cells in white matter lesions from human preterm neonates and adults with multiple sclerosis. FoxO3 constraint of OPC maturation was bHAf dependent, and involved interactions at the FoxO3 and MBP promoters with the chromatin remodeling factor Brg1 and the transcription factor Olig2, which regulate OPC differentiation. WMI has adapted an immune tolerance–like mechanism whereby persistent engagement of TLR4 by bHAf promotes an OPC niche at the expense of myelination by engaging a FoxO3 signaling pathway that chronically constrains OPC differentiation.

Authors

Taasin Srivastava, Parham Diba, Justin M. Dean, Fatima Banine, Daniel Shaver, Matthew Hagen, Xi Gong, Weiping Su, Ben Emery, Daniel L. Marks, Edward N. Harris, Bruce Baggenstoss, Paul H. Weigel, Larry S. Sherman, Stephen A. Back

×

Figure 2

A distinct bHAf blocks OPC maturation.

Options: View larger image (or click on image) Download as PowerPoint
A distinct bHAf blocks OPC maturation.
(A–C) Rat slices cultured 21 days...
(A–C) Rat slices cultured 21 days display extensive myelination. (A) Nodes of Ranvier identified with CASPR (red arrowheads). (B) Representative ultrastructural images of early (left panel) and late (right panel) myelination and detail of multilamellar myelin sheaths (insets). (C) Schematic of strategy to analyze chronic in vitro myelination. prep, prepared from. Representative images of myelinated axons in callosal WM visualized with MBP and 200 kDa neurofilament H (NFH) after treatment with DMSO (vehicle), MDa HA (50 nM) with or without VCPAL (25 μM), or bHAf (100 nM). (D) 175–300 kDa HAf regulates OPC maturation cell autonomously. Primary OPCs cultured 4 days under pro-differentiation conditions stained for OPCs (PDGFRα, green), OLs (MBP, red), and DAPI (blue). Cultures treated with PBS (vehicle), MDa HA (50 nM), HAf 175–300 kDa (500 nM), or HAf 5–20 kDa (500 nM). Quantification of total OPCs and OLs. (E) MBP+ OLs in DIV8 slices cultured with PBS (vehicle) or HAf of 40 (100 nM), 106 (100 nM), 210 (100 nM) or 357 kDa (100 nM). (F) Primary OPCs differentiated 4 days with or without bHAf (500 nM) visualized with cyclic nucleotide phosphodiesterase (CNP), MBP, and DAPI (left). bHAF treatment decreased the percentage of OLs (right). (G) Density of OLs in DIV8 slices cultured with varying bHAf concentrations. (H) OL quantification in DIV8 slices cultured with bHAf (100 nM) and equimolar concentrations of HAf at 357 or 106 kDa or combined with 357-kDa and 106-kDa HAf (100 nM). A, C, and E: n = 3 animals/condition from separate litters; 3 slices/treatment condition/animal, 9 slices total. D and F: n = 2 separate culture preparations. G and H: n = 1 animal per condition; 3 slices analyzed per treatment condition. *P < 0.05 by Student’s t test; **P < 0.001 by ANOVA; mean ± SD. Scale bars: 12 μm, A; 600 nm, B (insets: original magnification, ×33,000); 150 μm, C; 75 μm, D and F.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts